IBDEI0AU ; ; 12-JAN-2012
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JAN 12, 2012
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4)
 ;;=^IBE(358.4,
 ;;^UTILITY(U,$J,358.4,0)
 ;;=IMP/EXP SELECTION GROUP^358.4I^928^928
 ;;^UTILITY(U,$J,358.4,1,0)
 ;;=ADJUSTMENT DISORDERS^1^1
 ;;^UTILITY(U,$J,358.4,2,0)
 ;;=ANXIETY DISORDERS^3^1
 ;;^UTILITY(U,$J,358.4,3,0)
 ;;=AMNESTICS^2^1
 ;;^UTILITY(U,$J,358.4,4,0)
 ;;=ORGANIC DISORDERS^9^1
 ;;^UTILITY(U,$J,358.4,5,0)
 ;;=DEMENTIA^5^1
 ;;^UTILITY(U,$J,358.4,6,0)
 ;;=DELIRIUM^4^1
 ;;^UTILITY(U,$J,358.4,7,0)
 ;;=BIPOLAR DISORDERS^3.5^1
 ;;^UTILITY(U,$J,358.4,8,0)
 ;;=PSYCHOSIS^12^1
 ;;^UTILITY(U,$J,358.4,9,0)
 ;;=PERSONALITY DISORDERS^11^1
 ;;^UTILITY(U,$J,358.4,10,0)
 ;;=SEXUAL DISORDERS^14^1
 ;;^UTILITY(U,$J,358.4,11,0)
 ;;=SLEEP DISORDERS^15^1
 ;;^UTILITY(U,$J,358.4,12,0)
 ;;=OTHER DISORDERS^19^1
 ;;^UTILITY(U,$J,358.4,13,0)
 ;;=SUBSTANCE RELATED DISORDERS^0^1
 ;;^UTILITY(U,$J,358.4,14,0)
 ;;=V CODES^17^1
 ;;^UTILITY(U,$J,358.4,15,0)
 ;;=PREVENTION/COUNSELING/SCREEN^20^1
 ;;^UTILITY(U,$J,358.4,16,0)
 ;;=DEPRESSION^6^1
 ;;^UTILITY(U,$J,358.4,17,0)
 ;;=MOOD DISORDERS (OTHER)^8^1
 ;;^UTILITY(U,$J,358.4,18,0)
 ;;=SCHIZOPHRENIA^13^1
 ;;^UTILITY(U,$J,358.4,19,0)
 ;;=SOMATIFORM DISORDERS^16^1
 ;;^UTILITY(U,$J,358.4,20,0)
 ;;=EATING DISORDERS^7^1
 ;;^UTILITY(U,$J,358.4,21,0)
 ;;=OTHER PROVIDER'S CODES^4^2
 ;;^UTILITY(U,$J,358.4,22,0)
 ;;=PRESCRIBER CODES^1^2
 ;;^UTILITY(U,$J,358.4,23,0)
 ;;=PSYCHOTHERAPY (MSW/PhD/Prescriber)^2^2
 ;;^UTILITY(U,$J,358.4,24,0)
 ;;=OTHER CODES^3^2
 ;;^UTILITY(U,$J,358.4,25,0)
 ;;=ESTABLISHED PATIENT^2^3
 ;;^UTILITY(U,$J,358.4,26,0)
 ;;=EAR DISEASES^1^4
 ;;^UTILITY(U,$J,358.4,27,0)
 ;;=FACTOR INFLUENCING HEALTH^2^4
 ;;^UTILITY(U,$J,358.4,28,0)
 ;;=HEARING LOSS (HL)^14^4
 ;;^UTILITY(U,$J,358.4,29,0)
 ;;=OTHER^15^4
 ;;^UTILITY(U,$J,358.4,30,0)
 ;;=NYSTAGMUS^17^4
 ;;^UTILITY(U,$J,358.4,31,0)
 ;;=AUDIOLOGIC FUNCTION TESTS^1^5
 ;;^UTILITY(U,$J,358.4,32,0)
 ;;=SCREENING^3^5
 ;;^UTILITY(U,$J,358.4,33,0)
 ;;=OTHER^11^5
 ;;^UTILITY(U,$J,358.4,34,0)
 ;;=COCHLEAR IMPLANT^13^5
 ;;^UTILITY(U,$J,358.4,35,0)
 ;;=OTHER TREATMENT^15^5
 ;;^UTILITY(U,$J,358.4,36,0)
 ;;=DISPENSING^17^5
 ;;^UTILITY(U,$J,358.4,37,0)
 ;;=REMOVAL FOREIGN BODY/CERUMEN^19^5
 ;;^UTILITY(U,$J,358.4,38,0)
 ;;=VESTIBULAR FUNCTION TESTS w/RECORDING^21^5
 ;;^UTILITY(U,$J,358.4,39,0)
 ;;=VESTIBULA FUNCTION W/O RECORDING^23^5
 ;;^UTILITY(U,$J,358.4,40,0)
 ;;=HA ORIENTATION^25^5
 ;;^UTILITY(U,$J,358.4,41,0)
 ;;=TYPE OF VISIT^1^6
 ;;^UTILITY(U,$J,358.4,42,0)
 ;;=CONTRIBUTORY COND (MARK ALL THAT APPLY)^2^7
 ;;^UTILITY(U,$J,358.4,43,0)
 ;;=IMPAIRMENT CODES-COND TREATED^1^7
 ;;^UTILITY(U,$J,358.4,44,0)
 ;;=TBI-RELATED CONTRIB COND^3^7
 ;;^UTILITY(U,$J,358.4,45,0)
 ;;=PRIMARY DX (REASON FOR VISIT)^1^8
 ;;^UTILITY(U,$J,358.4,46,0)
 ;;=ASSESSMENT/COUNSELING^2^9
 ;;^UTILITY(U,$J,358.4,47,0)
 ;;=ONE ON ONE TRAINING^3^9
 ;;^UTILITY(U,$J,358.4,48,0)
 ;;=GROUP/FAMILY TRAINING^4^9
 ;;^UTILITY(U,$J,358.4,49,0)
 ;;=TEAM CONFERENCE^5^9
 ;;^UTILITY(U,$J,358.4,50,0)
 ;;=MISC.^6^9
 ;;^UTILITY(U,$J,358.4,51,0)
 ;;=HOME VISIT^1^9
 ;;^UTILITY(U,$J,358.4,52,0)
 ;;=MYOCARDIAL INFARCTION^9^10
 ;;^UTILITY(U,$J,358.4,53,0)
 ;;=CHF / MYOPATHY / TRANSPLANT^3^10
 ;;^UTILITY(U,$J,358.4,54,0)
 ;;=ARRHYTHMIA^1^10
 ;;^UTILITY(U,$J,358.4,55,0)
 ;;=PERIPHERAL VASC DIS^10^10
 ;;^UTILITY(U,$J,358.4,56,0)
 ;;=INFECT/INFLAM DISEASE^7^10
 ;;^UTILITY(U,$J,358.4,57,0)
 ;;=SYNCOPE/HYPOTENSION^12^10
 ;;^UTILITY(U,$J,358.4,58,0)
 ;;=GENERAL SYMPTOMS^5^10
 ;;^UTILITY(U,$J,358.4,59,0)
 ;;=LIPID DISORDERS^8^10
 ;;^UTILITY(U,$J,358.4,60,0)
 ;;=SCREENING DEVICES^11^10
 ;;^UTILITY(U,$J,358.4,61,0)
 ;;=CHEST PAIN^2^10
 ;;^UTILITY(U,$J,358.4,62,0)
 ;;=CORONARY ATHEROSCLEROSIS^4^10
 ;;^UTILITY(U,$J,358.4,63,0)
 ;;=OTHER FORMS OF HEART DISEASE^13^10
 ;;^UTILITY(U,$J,358.4,64,0)
 ;;=HYPERTENSION^6^10
 ;;^UTILITY(U,$J,358.4,65,0)
 ;;=NONRHEUMATIC HEART VALVE DISEASE^14^10
 ;;^UTILITY(U,$J,358.4,66,0)
 ;;=RHEUMATIC HEART DISEASE^15^10
 ;;^UTILITY(U,$J,358.4,67,0)
 ;;=OTHER HEART VALVE DISEASE^16^10
 ;;^UTILITY(U,$J,358.4,68,0)
 ;;=PACEMAKER^5^11
 ;;^UTILITY(U,$J,358.4,69,0)
 ;;=CORONARY ANGIOPLASTY & STENTS^3^11
 ;;^UTILITY(U,$J,358.4,70,0)
 ;;=ELECTROPHYSIOLOGICAL PROCs^4^11
 ;;^UTILITY(U,$J,358.4,71,0)
 ;;=PERIPHERAL ANGIOPLASTIES & STENTS^7^11
 ;;^UTILITY(U,$J,358.4,72,0)
 ;;=VASCULAR INJECTION PROCs^8^11
 ;;^UTILITY(U,$J,358.4,73,0)
 ;;=OTHER PROCEDURES^9^11
 ;;^UTILITY(U,$J,358.4,74,0)
 ;;=HEART CATHETERIZATIONS^1^11
 ;;^UTILITY(U,$J,358.4,75,0)
 ;;=CATHETERIZATIONS FOR INT RADIOLOGY^6^11
 ;;^UTILITY(U,$J,358.4,76,0)
 ;;=OTHER HEART CODES/ECHO^3.5^11
 ;;^UTILITY(U,$J,358.4,77,0)
 ;;=PROSTHETIC ANEURYSM REPAIR^10^11
 ;;^UTILITY(U,$J,358.4,78,0)
 ;;=EKG^1^12
 ;;^UTILITY(U,$J,358.4,79,0)
 ;;=OTHER CARDIAC^4^12
 ;;^UTILITY(U,$J,358.4,80,0)
 ;;=ECHO^3^12
 ;;^UTILITY(U,$J,358.4,81,0)
 ;;=STRESS TESTS^5^12
 ;;^UTILITY(U,$J,358.4,82,0)
 ;;=DEVICE PROGRAMMING^5^12
 ;;^UTILITY(U,$J,358.4,83,0)
 ;;=NEW PATIENT^2^13
 ;;^UTILITY(U,$J,358.4,84,0)
 ;;=ESTABLISHED PATIENT^1^13
 ;;^UTILITY(U,$J,358.4,85,0)
 ;;=CONSULTATIONS^3^13
 ;;^UTILITY(U,$J,358.4,86,0)
 ;;=MYOCARDIAL INFARCTION^9^14
 ;;^UTILITY(U,$J,358.4,87,0)
 ;;=CHF/MYOPATHY/TRANSPLANT^3^14
 ;;^UTILITY(U,$J,358.4,88,0)
 ;;=ARRHYTHMIA^1^14
 ;;^UTILITY(U,$J,358.4,89,0)
 ;;=PERIPHERAL VASC DIS^10^14
 ;;^UTILITY(U,$J,358.4,90,0)
 ;;=INFECT/INFLAM DISEASE^7^14
 ;;^UTILITY(U,$J,358.4,91,0)
 ;;=SYNCOPE/HYPOTENSION^12^14
 ;;^UTILITY(U,$J,358.4,92,0)
 ;;=GENERAL SYMPTOMS^5^14
 ;;^UTILITY(U,$J,358.4,93,0)
 ;;=LIPID DISORDERS^8^14
 ;;^UTILITY(U,$J,358.4,94,0)
 ;;=SCREENING DEVICES^11^14
 ;;^UTILITY(U,$J,358.4,95,0)
 ;;=CHEST PAIN^2^14
 ;;^UTILITY(U,$J,358.4,96,0)
 ;;=CORONARY ATHEROSCLEROSIS^4^14
 ;;^UTILITY(U,$J,358.4,97,0)
 ;;=OTHER FORMS OF HEART DISEASE^13^14
 ;;^UTILITY(U,$J,358.4,98,0)
 ;;=HYPERTENSION^6^14
 ;;^UTILITY(U,$J,358.4,99,0)
 ;;=NONRHEUMATIC HEART VALVE DISEASE^14^14
 ;;^UTILITY(U,$J,358.4,100,0)
 ;;=RHEUMATIC HEART DISEASE^15^14
 ;;^UTILITY(U,$J,358.4,101,0)
 ;;=OTHER HEART VALVE DISEASE^16^14
 ;;^UTILITY(U,$J,358.4,102,0)
 ;;=NEW PATIENT^2^15
 ;;^UTILITY(U,$J,358.4,103,0)
 ;;=ESTABLISHED PATIENT^1^15
 ;;^UTILITY(U,$J,358.4,104,0)
 ;;=CONSULTATIONS^3^15
 ;;^UTILITY(U,$J,358.4,105,0)
 ;;=MISCELLANEOUS TREATMENT^3^16
 ;;^UTILITY(U,$J,358.4,106,0)
 ;;=CHIROPRACTIC MANIPULATIVE SERVICES^0^16
 ;;^UTILITY(U,$J,358.4,107,0)
 ;;=MUSCULOSKELETAL/CONNECTIVE TISSUE^1^17
 ;;^UTILITY(U,$J,358.4,108,0)
 ;;=OTHER^3^18
 ;;^UTILITY(U,$J,358.4,109,0)
 ;;=COMMONLY USED CODES^1^18
 ;;^UTILITY(U,$J,358.4,110,0)
 ;;=WARFARIN CLINIC CODES^2^18
 ;;^UTILITY(U,$J,358.4,111,0)
 ;;=PRIMARY DIAGNOSIS^1^19
 ;;^UTILITY(U,$J,358.4,112,0)
 ;;=NEW PATIENT^1^20
 ;;^UTILITY(U,$J,358.4,113,0)
 ;;=ESTABLISHED PATIENT^2^20
 ;;^UTILITY(U,$J,358.4,114,0)
 ;;=EDUCATION & TRAINING FOR SELF MGMT^3^20
 ;;^UTILITY(U,$J,358.4,115,0)
 ;;=SECONDARY V CODES AS APPROPRIATE^1^21
 ;;^UTILITY(U,$J,358.4,116,0)
 ;;=C&P EXAM^1^22
 ;;^UTILITY(U,$J,358.4,117,0)
 ;;=LENGTHY/COMPLEX C-FILE REVIEW^1^23
 ;;^UTILITY(U,$J,358.4,118,0)
 ;;=PRIMARY DIAGNOSIS^1^24
 ;;^UTILITY(U,$J,358.4,119,0)
 ;;=NEW PATIENT^2^25
 ;;^UTILITY(U,$J,358.4,120,0)
 ;;=ESTABLISHED PATIENT^1^25
 ;;^UTILITY(U,$J,358.4,121,0)
 ;;=CONSULTATIONS^3^25
 ;;^UTILITY(U,$J,358.4,122,0)
 ;;=DEBRIDEMENT^1^26
 ;;^UTILITY(U,$J,358.4,123,0)
 ;;=DESTRUCTION-BENIGN OR PREMALIG LESIONS^2^26
 ;;^UTILITY(U,$J,358.4,124,0)
 ;;=DEST MAL LESION-TRUNK,ARMS,LEGS^3^26
 ;;^UTILITY(U,$J,358.4,125,0)
 ;;=EXC-BEN LESION-TRUNK,ARM,LEG^6^26
 ;;^UTILITY(U,$J,358.4,126,0)
 ;;=EXC-MAL LESION-TRUNK,ARM,LEG^9^26
 ;;^UTILITY(U,$J,358.4,127,0)
 ;;=INCISION & DRAINAGE^12^26
 ;;^UTILITY(U,$J,358.4,128,0)
 ;;=MISCELLANEOUS^13^26
 ;;^UTILITY(U,$J,358.4,129,0)
 ;;=NAILS^14^26
 ;;^UTILITY(U,$J,358.4,130,0)
 ;;=SHAVING-EPIDERMAL/TRUNK,ARM,LEG^15^26
 ;;^UTILITY(U,$J,358.4,131,0)
 ;;=REPAIR-SIMPLE-SCALP,NK,TRUNK^18^26
 ;;^UTILITY(U,$J,358.4,132,0)
 ;;=REPAIR-INTERM-SCALP,TRUNK^20^26
 ;;^UTILITY(U,$J,358.4,133,0)
 ;;=DEST MAL LES-SCALP,NK,HAND,FEET,GENITALS^4^26
 ;;^UTILITY(U,$J,358.4,134,0)
 ;;=DEST MAL LESION-FACE,MUCOUS^5^26
 ;;^UTILITY(U,$J,358.4,135,0)
 ;;=EXC-BEN LESION-SCALP,HANDS,FT,GENITALS^7^26
 ;;^UTILITY(U,$J,358.4,136,0)
 ;;=EXC-BEN LESION-FACE,MUCOUS^8^26
 ;;^UTILITY(U,$J,358.4,137,0)
 ;;=EXC-MAL LESION-SCALP,NK,HAND,FT,GENITALS^10^26
 ;;^UTILITY(U,$J,358.4,138,0)
 ;;=EXC-MAL LESION-FACE,MUCOUS^11^26
 ;;^UTILITY(U,$J,358.4,139,0)
 ;;=SHAVING-EPIDERM-SCALP,NK,HAND,FT,GENITAL^16^26
 ;;^UTILITY(U,$J,358.4,140,0)
 ;;=SHAVING-EPIDERM-FACE,MUCOUS^17^26
 ;;^UTILITY(U,$J,358.4,141,0)
 ;;=REPAIR-SIMPLE-FACE,MUCOUS^19^26
 ;;^UTILITY(U,$J,358.4,142,0)
 ;;=REPAIR-INTERM-NK,HAND,FT,GENITALIA^21^26
 ;;^UTILITY(U,$J,358.4,143,0)
 ;;=REPAIR-INTERM-FACE,MUCOUS^22^26
 ;;^UTILITY(U,$J,358.4,144,0)
 ;;=ABRASION w/o INFECTION^1^27
 ;;^UTILITY(U,$J,358.4,145,0)
 ;;=ABRASION w/ INFECTION^2^27
 ;;^UTILITY(U,$J,358.4,146,0)
 ;;=ABSCESS/CELLULITIS^3^27
 ;;^UTILITY(U,$J,358.4,147,0)
 ;;=ACNE^4^27
 ;;^UTILITY(U,$J,358.4,148,0)
 ;;=ALOPEICA^5^27
 ;;^UTILITY(U,$J,358.4,149,0)
 ;;=BURNS^6^27
 ;;^UTILITY(U,$J,358.4,150,0)
 ;;=CANDIDIASIS^7^27
 ;;^UTILITY(U,$J,358.4,151,0)
 ;;=CELLULITIS^8^27
 ;;^UTILITY(U,$J,358.4,152,0)
 ;;=DERMATITIS^9^27
 ;;^UTILITY(U,$J,358.4,153,0)
 ;;=DERMATOPHYTOSIS^10^27
 ;;^UTILITY(U,$J,358.4,154,0)
 ;;=ECZEMA^11^27
 ;;^UTILITY(U,$J,358.4,155,0)
 ;;=EDEMA^12^27
 ;;^UTILITY(U,$J,358.4,156,0)
 ;;=ERYTHEMA^13^27
 ;;^UTILITY(U,$J,358.4,157,0)
 ;;=EXPOSURE TO HEALTH HAZARDS^14^27
 ;;^UTILITY(U,$J,358.4,158,0)
 ;;=FOLLICULITIS^15^27
 ;;^UTILITY(U,$J,358.4,159,0)
 ;;=FURUNCLE^16^27
 ;;^UTILITY(U,$J,358.4,160,0)
 ;;=GRANULOMA^17^27
 ;;^UTILITY(U,$J,358.4,161,0)
 ;;=HERPES^35^27
 ;;^UTILITY(U,$J,358.4,162,0)
 ;;=HISTORY^36^27
 ;;^UTILITY(U,$J,358.4,163,0)
 ;;=ICHTHYOSIS^38^27
 ;;^UTILITY(U,$J,358.4,164,0)
 ;;=INSECT BITE w/o INFECTION^39^27
 ;;^UTILITY(U,$J,358.4,165,0)
 ;;=INSECT BITE w/INFECTION^40^27
 ;;^UTILITY(U,$J,358.4,166,0)
 ;;=KERATOSIS^42^27
